Document 2638 DOCN M94A2638 TI Neurological manifestation in parenterally HIV-1 infected children in Russia. DT 9412 AU Rakhmanova A; Fomin J; Chernykh M; Popova I; Burova N; Fomina M; Russian Clinical HIV-AIDS center, St.-Petersburg. SO Int Conf AIDS. 1994 Aug 7-12;10(1):259 (abstract no. PB0466). Unique Identifier : AIDSLINE ICA10/94369937 AB OBJECTIVE: The prevalence of central nervous system (CNS) disease in HIV-1 infected children have been reported in several series to vary between 8% and 62%. The aim was to describe CNS diseases in russian children infected HIV-1 by parenteral route. METHODS: 76 HIV-1 infected children were enrolled in surveillance from 1/91 to 10/93 year. The most of them were in 5-7 year age group. All children were infected HIV-1 five years ago in hospitals where they were with any serious illnesses. Clinical histories were reviewed to collect data. At time of the analyses 45 patients had ARC, 16--AIDS, 8--have died. RESULTS: Of 76 enrolled children 64 (81.5%) have had signs of CNS disease (delay psychomotor and language developing, neurological signs). Fifty one from those 64 patients before expose to HIV have had multiply risk factor for encephalopathy due to events in perinatal period (prematurity, in utero infections, severe hypoxic injury). 8 (12.5%) patients have had HIV-related encephalopathy diagnosed by clinical exams and computed tomographic scans. 6 children with HIV-related CNS disease were long-treated by oral Retrovir (Wellcome) and have surviving more than 2 years without progression CNS symptoms. Two other patients have not been treated and died in 6-9 month after HIV-related encephalopathy have been diagnosed. CONCLUSION: 1. The diagnose of HIV-related CNS disease was difficult for multiply risk factor preceding HIV infection. 2. Retrovir was useful for treatment HIV-related encephalopathy in children. DE AIDS Dementia Complex/*DIAGNOSIS Child Child, Preschool Follow-Up Studies Human HIV Infections/*DIAGNOSIS/TRANSMISSION *HIV-1 *Neurologic Examination Risk Factors Russia MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).